Home › Cytopenia › New York
Cytopenia clinical trials in New York
4 studies for Cytopenia are looking for participants at sites in New York.
Cities in New York
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
- New York Cancer and Blood, Shirley
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT04419649A Study of Emapalumab for Pediatric Aplastic Anemia
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
RecruitingPhase 2Healthy volunteers welcome
Ages 0 to 25 · All sexes · Updated Dec 17, 2025 · NCT06430788From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.